ZA904227B - Chroman derivatives - Google Patents

Chroman derivatives

Info

Publication number
ZA904227B
ZA904227B ZA904227A ZA904227A ZA904227B ZA 904227 B ZA904227 B ZA 904227B ZA 904227 A ZA904227 A ZA 904227A ZA 904227 A ZA904227 A ZA 904227A ZA 904227 B ZA904227 B ZA 904227B
Authority
ZA
South Africa
Prior art keywords
chroman derivatives
chroman
derivatives
Prior art date
Application number
ZA904227A
Other languages
English (en)
Inventor
Rolf Gericke
Gericke Rolf
Ingeborg Lues
Lues Ingeborg
Jacques De Peyer
De Peyer Jacques
Manfred Baumgarth
Baumgarth Manfred
Rolf Bergmann
Bergmann Rolf
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA904227B publication Critical patent/ZA904227B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA904227A 1989-06-02 1990-06-01 Chroman derivatives ZA904227B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918041A DE3918041A1 (de) 1989-06-02 1989-06-02 Chromanderivate

Publications (1)

Publication Number Publication Date
ZA904227B true ZA904227B (en) 1991-03-27

Family

ID=6381944

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA904227A ZA904227B (en) 1989-06-02 1990-06-01 Chroman derivatives

Country Status (20)

Country Link
US (1) US5112972A (sv)
EP (1) EP0400430B1 (sv)
JP (1) JPH0320275A (sv)
KR (1) KR910000713A (sv)
AR (1) AR245715A1 (sv)
AT (1) ATE110072T1 (sv)
AU (1) AU623780B2 (sv)
CA (1) CA2017961A1 (sv)
DE (2) DE3918041A1 (sv)
DK (1) DK0400430T3 (sv)
ES (1) ES2057262T3 (sv)
FI (1) FI95701C (sv)
HU (1) HUT58323A (sv)
IE (1) IE65098B1 (sv)
IL (1) IL94256A (sv)
NO (1) NO175976C (sv)
NZ (1) NZ233912A (sv)
PT (1) PT94225B (sv)
TW (1) TW210338B (sv)
ZA (1) ZA904227B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
JP3442815B2 (ja) * 1992-05-13 2003-09-02 第一製薬株式会社 ジアザビシクロアルケン誘導体
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
US5719155A (en) * 1993-11-10 1998-02-17 Japan Tobacco Inc. Chroman derivative and pharmaceutical use thereof
US5470861A (en) * 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
AU7319800A (en) 1999-09-24 2001-04-24 Nissan Chemical Industries Ltd. 4-oxybenzopyran derivative
EP1218367A1 (en) * 1999-10-05 2002-07-03 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
ES2311727T3 (es) 2002-11-12 2009-02-16 Warner-Lambert Company Llc Procedimiento de estimulacion del crecimiento del cabello usando benzopiranos.
BRPI0519013A2 (pt) * 2004-12-13 2009-11-03 Lilly Co Eli composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto
EP1940516A2 (en) * 2005-09-01 2008-07-09 Janssen Pharmaceutica, N.V. Benzopyran and pyranopyridine derivatives as potassium channel openers
WO2024040267A2 (en) * 2022-08-19 2024-02-22 Mitokinin, Inc. Direct synthesis of n-(3-substituted-chroman-4-yl)-7h- pyrrolo[2,3-d]pyrimidin-4-amines and derivatives thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3274350D1 (en) * 1981-09-25 1987-01-08 Beecham Group Plc Pharmaceutically active benzopyran compounds
EP0091748B1 (en) * 1982-04-08 1986-06-18 Beecham Group Plc Antihypertensive benzopyranols
EP0093534A1 (en) * 1982-04-28 1983-11-09 Beecham Group Plc Novel chromanols
GB8419516D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
FR2615191B1 (fr) * 1987-05-16 1991-01-11 Sandoz Sa Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (de) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Chromanderivate

Also Published As

Publication number Publication date
IL94256A0 (en) 1991-03-10
AU623780B2 (en) 1992-05-21
EP0400430A3 (de) 1991-01-02
EP0400430B1 (de) 1994-08-17
IL94256A (en) 1994-04-12
IE65098B1 (en) 1995-10-04
HUT58323A (en) 1992-02-28
ATE110072T1 (de) 1994-09-15
IE901988A1 (en) 1991-01-02
PT94225A (pt) 1991-02-08
JPH0320275A (ja) 1991-01-29
DE59006817D1 (de) 1994-09-22
DE3918041A1 (de) 1990-12-06
HU903293D0 (en) 1990-10-28
IE901988L (en) 1990-12-02
NO175976B (no) 1994-10-03
NO902459D0 (no) 1990-06-01
DK0400430T3 (da) 1994-09-12
KR910000713A (ko) 1991-01-30
NO175976C (no) 1995-01-11
NO902459L (no) 1990-12-03
NZ233912A (en) 1992-10-28
ES2057262T3 (es) 1994-10-16
PT94225B (pt) 1996-12-31
FI95701B (sv) 1995-11-30
AR245715A1 (es) 1994-02-28
TW210338B (sv) 1993-08-01
CA2017961A1 (en) 1990-12-02
FI902727A0 (sv) 1990-06-01
AU5600790A (en) 1990-12-06
EP0400430A2 (de) 1990-12-05
US5112972A (en) 1992-05-12
FI95701C (sv) 1996-03-11

Similar Documents

Publication Publication Date Title
AP9000175A0 (en) 3-substituted-2-oxindole derivatives
EP0430709A3 (en) Benzthiophen derivatives
IL90198A0 (en) Chroman derivatives
EP0431421A3 (en) Heteroarylsubstituted pyridinylpyrimidin derivatives
GB2229723B (en) Thieno-triazolo-diazepine derivatives
IL94256A0 (en) Chroman derivatives
ZA906144B (en) Chroman derivatives
IL95167A0 (en) Chroman derivatives
ZA897783B (en) Chroman derivatives
GB2231330B (en) Thieno-triazolo-diazepine derivatives
ZA905325B (en) Chroman derivatives
EP0431424A3 (en) Pyridinylpyrimidin derivatives
AU5911190A (en) 4-phenylpyridonyl chroman derivatives
GB2229724B (en) Thieno-triazolo-diazepine derivatives
EP0479951A4 (en) Bis-acyloxymethyl derivatives
GB8918275D0 (en) Fluoro-chloro-benzene derivatives
EP0411636A3 (en) Piperidylthiocarbapenem derivatives
EP0438686A3 (en) Triazolylmethyl-cyclopropyl derivatives
ZA893341B (en) Chroman derivatives
GB2238310B (en) Selenophen derivatives
ZA894619B (en) Chroman derivatives
EP0422450A3 (en) Chroman derivatives
IE893311L (en) Chroman derivatives
IL89618A0 (en) Chromone derivatives
EP0409296A3 (en) Cardanolactam derivatives